Once existing in obscurity, SGLTs are now a focus of interest in the medical community, after it was discovered that inhibition of SGLT2 can result in improved plasma glucose control for patients living with diabetes mellitus type 2 (DMT2). Here, SLC5A2 is linked to diabetes mellitus.